Secondary malignant neoplasm of other and unspecified sites C79
- C79 should not be used for reimbursement purposes. Please select a more specific diagnosis below.
- The 2019 edition of ICD-10-CM C79 became effective on October 1, 2018.
- This is the American ICD-10-CM version of C79 - other international versions of ICD-10 C79 may differ.
Type 1 Excludes:
- secondary carcinoid tumors (C7B.-)
- secondary neuroendocrine tumors (C7B.-)
Codes: = Billable
-
C79 Secondary malignant neoplasm of other and unspecified sites
- C79.0 Secondary malignant neoplasm of kidney and renal pelvis
- C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
- C79.2 Secondary malignant neoplasm of skin
- C79.3 Secondary malignant neoplasm of brain and cerebral meninges
- C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
- C79.5 Secondary malignant neoplasm of bone and bone marrow
- C79.6 Secondary malignant neoplasm of ovary
- C79.7 Secondary malignant neoplasm of adrenal gland
- C79.8 Secondary malignant neoplasm of other specified sites
- C79.9 Secondary malignant neoplasm of unspecified site
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.